Literature DB >> 26550561

Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia.

Brooke E Hjelm1, Brandi Rollins1, Firoza Mamdani1, Julie C Lauterborn2, George Kirov3, Gary Lynch4, Christine M Gall5, Adolfo Sequeira1, Marquis P Vawter1.   

Abstract

Genetic evidence has supported the hypothesis that schizophrenia (SZ) is a polygenic disorder caused by the disruption in function of several or many genes. The most common and reproducible cellular phenotype associated with SZ is a reduction in dendritic spines within the neocortex, suggesting alterations in dendritic architecture may cause aberrant cortical circuitry and SZ symptoms. Here, we review evidence supporting a multifactorial model of mitochondrial dysfunction in SZ etiology and discuss how these multiple paths to mitochondrial dysfunction may contribute to dendritic spine loss and/or underdevelopment in some SZ subjects. The pathophysiological role of mitochondrial dysfunction in SZ is based upon genomic analyses of both the mitochondrial genome and nuclear genes involved in mitochondrial function. Previous studies and preliminary data suggest SZ is associated with specific alleles and haplogroups of the mitochondrial genome, and also correlates with a reduction in mitochondrial copy number and an increase in synonymous and nonsynonymous substitutions of mitochondrial DNA. Mitochondrial dysfunction has also been widely implicated in SZ by genome-wide association, exome sequencing, altered gene expression, proteomics, microscopy analyses, and induced pluripotent stem cell studies. Together, these data support the hypothesis that SZ is a polygenic disorder with an enrichment of mitochondrial targets.

Entities:  

Keywords:  Antipsychotic drug; Dendritic spines; Fluorescence deconvolution tomography; Genome; Induced pluripotent stem cell; Mitochondria; Polygenic disorder; Proteome; Schizophrenia; Transcriptome

Year:  2015        PMID: 26550561      PMCID: PMC4635522          DOI: 10.1159/000441252

Source DB:  PubMed          Journal:  Mol Neuropsychiatry        ISSN: 2296-9179


  124 in total

1.  Mitochondria impact brain function and cognition.

Authors:  Martin Picard; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

2.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia.

Authors:  Firoza Mamdani; Brandi Rollins; Ling Morgan; P Adolfo Sequeira; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-09-28       Impact factor: 4.939

Review 3.  Mitochondria and neuroplasticity.

Authors:  Aiwu Cheng; Yan Hou; Mark P Mattson
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 4.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

5.  Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.

Authors:  Cao Huang; Jianbin Tong; Fangfang Bi; Qinxue Wu; Bo Huang; Hongxia Zhou; Xu-Gang Xia
Journal:  Hum Mol Genet       Date:  2012-07-23       Impact factor: 6.150

6.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

7.  Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs.

Authors:  Shirly Amar; Alon Shamir; Ofer Ovadia; Monica Blanaru; Alon Reshef; Ilana Kremer; Marcella Rietschel; Thomas G Schulze; Wolfgang Maier; R H Belmaker; Richard P Ebstein; Galila Agam; Dan Mishmar
Journal:  Schizophr Res       Date:  2007-06-12       Impact factor: 4.939

8.  Induced pluripotent stem cells with a mitochondrial DNA deletion.

Authors:  Anne B C Cherry; Katelyn E Gagne; Erin M McLoughlin; Anna Baccei; Bryan Gorman; Odelya Hartung; Justine D Miller; Jin Zhang; Rebecca L Zon; Tan A Ince; Ellis J Neufeld; Paul H Lerou; Mark D Fleming; George Q Daley; Suneet Agarwal
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

9.  Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis.

Authors:  Nieves Cano-Cuenca; Julián E Solís-García del Pozo; Joaquín Jordán
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

View more
  36 in total

1.  Pinocembrin Suppresses H2O2-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Flávia Bittencourt Brasil; Alessandra Peres
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

3.  Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.

Authors:  Aarron Phensy; Kathy L Lindquist; Karen A Lindquist; Dania Bairuty; Esha Gauba; Lan Guo; Jing Tian; Heng Du; Sven Kroener
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

4.  A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.

Authors:  Vanessa F Gonçalves; Carolina Cappi; Christian M Hagen; Adolfo Sequeira; Marquis P Vawter; Andriy Derkach; Clement C Zai; Paula L Hedley; Jonas Bybjerg-Grauholm; Jennie G Pouget; Ari B Cuperfain; Patrick F Sullivan; Michael Christiansen; James L Kennedy; Lei Sun
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

Review 5.  Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.

Authors:  Prakash Devaraju; Stanislav S Zakharenko
Journal:  Bioessays       Date:  2017-01-03       Impact factor: 4.345

6.  Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis.

Authors:  Jamila Monteiro; Gabriela Assis-de-Lemos; Eduardo de-Souza-Ferreira; Adriana M Marques; Gilda A Neves; Mariana S Silveira; Antonio Galina
Journal:  J Bioenerg Biomembr       Date:  2019-12-18       Impact factor: 2.945

7.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

8.  Sex-Specific Neurodevelopmental Programming by Placental Insulin Receptors on Stress Reactivity and Sensorimotor Gating.

Authors:  Stefanie L Bronson; Jennifer C Chan; Tracy L Bale
Journal:  Biol Psychiatry       Date:  2016-12-30       Impact factor: 13.382

Review 9.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

10.  Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Smita S Jagtap; Donna McPhie; Roy H Perlis; Bruce M Cohen; Rakesh Karmacharya
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.